Effect of Two Multiple-dose Regimens of BIA 3-202 on the Pharmacokinetics and Motor Response of Levodopa, and on the Erythrocyte Comt Activity in Parkinson's Disease Patients

• Status: Completed
• Trial end date: 2005-11-01

Summary

The purpose of this study is to determine the effect of two different multiple-dose regimens of nebicapone in comparison to placebo and entacapone 200 mg on the pharmacokinetics of levodopa in Parkinson's Disease (PD) patients.

• Phase: Phase 2

Details

• Lead Sponsor: Bial - Portela C S.A.
• Treatments: Carbidopa; Carbidopa, levodopa drug combination; Entacapone; Levodopa